Metergoline
|
WikiDoc Resources for Metergoline |
|
Articles |
|---|
|
Most recent articles on Metergoline Most cited articles on Metergoline |
|
Media |
|
Powerpoint slides on Metergoline |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Metergoline at Clinical Trials.gov Clinical Trials on Metergoline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Metergoline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Metergoline Discussion groups on Metergoline Patient Handouts on Metergoline Directions to Hospitals Treating Metergoline Risk calculators and risk factors for Metergoline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Metergoline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Metergoline is a psychoactive drug of the ergoline chemical class which acts as a ligand for various serotonin and dopamine receptors.[1][2]
See also
References
- ↑ Hamon M, Mallat M, Herbet A; et al. (February 1981). "[3H]Metergoline: a new ligand of serotonin receptors in the rat brain". Journal of Neurochemistry. 36 (2): 613–26. doi:10.1111/j.1471-4159.1981.tb01634.x. PMID 7463079.
- ↑ Miller KJ, King A, Demchyshyn L, Niznik H, Teitler M (1992). "Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan". Eur. J. Pharmacol. 227 (1): 99–102. doi:10.1016/0922-4106(92)90149-P. PMID 1330643.